/Indian exec gets five years for fakes-making; AZ workers return to picket line;
NEWS

Indian exec gets five years for fakes-making; AZ workers return to picket line;

FiercePharma
2010/11/11

A director of Indian pharma company Axon Labs has earned five years in jail for manufacturing phony Sapagun tablets. Article

The Canadian Pharmaceutical Distribution Network has joined GHX, the Global Healthcare Exchange, to enhance connectivity with its hospital clients. CPDN release

Drug formulator Bend Research will work with Quotient Clinical to develop compounds for clinical trials and expand options for drug delivery. Bend release

Ghana has uncovered substandard and counterfeit versions of 13 antimalarial medicines across the country. Story

Medicago has earned an IRS grant for development work on a Virus-Like Particle vaccine. Medicago release

AstraZeneca workers in the U.K. are set to return to the picket line. News

A cut in the value of a Minnesota manufacturing facility and the delay of its sale have had little impact on Genmab, which reported reduced operating losses. Report

A 15 percent rise in pharma output contributed to a third-quarter boost in Ireland's manufacturing production. Story

Startup Gallus Biopharmaceuticals plans to buy and expand Johnson & Johnson's Centocor Biologics campus in St. Louis. Article

Thermo Fisher Scientific has added a 2,000-liter single-use bioreactor to its HyClone line. TFS release

Tate & Lyle will produce farnesene at its facilities in Decatur, IL, for Amyris. Amyris release

Summary

> A director of Indian pharma company Axon Labs has earned five years in jail for manufacturing phony Sapagun tablets. Article > The Canadian Pharmaceutical Distribution Network has joined GHX,